Abstract: The invention relates to the therapeutic use of a SMR1-peptide or a pharmaceutically active amount of said SMR1-peptide, for the preparation of a therapeutic composition for preventing or treating diseases wherein a modulation of the activity of a membrane metallopeptidase, notably a membrane-zinc metallopeptidase, is sought, in a mammal, specifically in a human.
Type:
Application
Filed:
November 8, 2006
Publication date:
March 8, 2007
Applicants:
INSTITUT PASTEUR, Centre National De La Racherche Scient